GlassScriptPhysician profile
Devin Gardner Dimond
NPI 1134521750
$5,490.97
in general payments reported to CMS, 2019-2025
14 companies · $321 in 2025
The $321 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17.76 · 2020: $99.31 · 2021: $1,647 · 2022: $2,094 · 2023: $1,117 · 2024: $194 · 2025: $321.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,048 · Travel and Lodging: $585.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,047.75 |
| Travel and Lodging | $584.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $2,576.76 | 2021-2025 | |
| Stryker Corporation | $2,222.88 | 2021-2025 | Gravity, Gravity Synchfix, Inbone |
| Paratek Pharmaceuticals, INC. | $210.71 | 2021 | |
| Smith+Nephew, INC. | $143.80 | 2025 | Stravix, Grafix |
| Rikco International, LLC | $90.00 | 2021 | |
| Mimedx Group, INC. | $66.30 | 2024-2025 | |
| Medela LLC | $32.00 | 2020 | |
| Djo, LLC | $31.88 | 2020 | |
| Evolution Surgical, INC | $29.99 | 2020 | |
| Organogenesis INC. | $25.64 | 2023 | Puraply |
| Acera Surgical, INC. | $23.56 | 2022 | |
| Kci USA, INC. | $14.25 | 2021 | |
| Tactile Systems Technology INC | $13.37 | 2019 | |
| Orthofix Medical, INC. | $9.83 | 2019-2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devin Dimond listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.